Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Culhaci, Nil ^a   Metin, Kubilay ^a   Copcu, Eray ^a   Dikicioglu, Emel ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1; COLLAGENASE; MMP13 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL BIOPSY; MAJOR CLINICAL STUDY; MALE; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TONGUE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; BIOPSY; BREAST TUMOR; FOLLOW UP; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLLAGENASES; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 13144295903     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-42     Document Type: Article

References (24)

1. Nakopoulou L, Giannopoulou I, Gakiopoulou H, Liapis H, Tzonou A, Davaris PS: Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999, 30:436-442.
2. Vaalamo M, Leivo T, Saarialho-Kere U: Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and - 4) in normal and aberrant wound healing. Hum Pathol 1999, 30:795-802.
3. Iki K, Tsutsumi M, Kido A, Sakitan H, Takahama M, Yoshimoto M, Motoyoma M, Tatsumi K, Tsunada T, Konishi Y: Expression of matrix metalloproteinase-2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of pro MMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis (2-oxopropyl amine. Carcinogenesis 1999, 20:1323-1329.
4. Maatta M, Soini Y, Liakka A, Autio-Harmainen H: Localization of MT1-MMP, TIMP-1, TIMP-2, TIMP-3, messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000, 114:402-411.
5. Werner JA, Rathcke IO, Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastas 2002, 19:275-282.
6. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behaviour. Annu Rev Cell Dev Biol 2001, 17: 63-516.
7. Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, Lopez-Otin C: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994, 269:16766-16773.
8. Leeman MF, McKay JA, Murray GI: Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002, 55:758-762.
9. Johansson N, Vaalamo M, Grenman S, Hietanen S, Klemi P, Saarialho-Kere U, Kahari VM: Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 1997, 154:469-480.
10. Nielsen BS, Rank F, Lopez JM, Balbin M, Vizoso F, Lund LR, Dano K, Lopez-Otin C: Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res 2001, 61:7091-7100.
11. Thomas GT, Lewis MP, Speight PM: Matrix metalloproteinases and oral cancer. Oral Oncol 1999, 35:227-233.
12. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K: Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999, 21:627-638.
13. Yoskizaki T, Maruyama Y, Sato H, Furukawa M: Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 2001, 95:44-50.
14. Polette M, Clavel C, Birembaut P: Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Path Res Pract 1993, 189:1052-1057.
15. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM: Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997, 151:499-508.
16. Sato H, Shimada Y, Watanabe G, Uchida S, Makino T, Imamura M: Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and e-cadherin in the process of lymph node metastasis in oesophageal cancer. Brit J Cancer 1999, 80: 366-1372.
17. O-charoenrat , Rhys-Evans PH, Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2001, 127:813-820.
18. Imanishi Y, Fuji M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y, Sato H: Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 2000, 31:895-904.
19. Riedel F, Götte K, Schwalb J, Hörmann K: Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res 2000, 20: 045-3050.
20. Airola K, Johansson N, Kariniemi AL, Kahari VM, Saarialho-Kere U: Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997, 109: 25-231.
21. Tsukifuji R, Tagawa K, Hatamochi A, Shinkai H: Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Brit J Cancer 1999, 80:1087-1091.
22. Ala-Aho R, Johansson N, Baker AH, Kahari VM: Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells. Int J Cancer 2002, 97:283-289.
23. Ala-Aho R, Grenman R, Seth P, Kahari VM: Adenoviral delivery of p53 gene suppresses expression of collagenase-3 in squamous carcinoma cells. Oncogene 2002, 21:1187-1195.
24. Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB: Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997, 106:271-278.